| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-06 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.001 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |